Shares of Marksans Pharma surged 16% to a record high of ₹217 in Wednesday’s trading on the BSE, driven by impressive financial results for the June 2024 quarter (Q1FY25). The stock hit an intra-day peak at ₹217 and was trading at ₹216.35, up 15% at 01:49 pm, outperforming the BSE Sensex, which rose just 0.24%.
Strong Q1 Performance
Marksans Pharma’s stock rallied following the…
